Key facts
- This page summarizes Mikael Dolsten's Form 4 filing for PFIZER INC (PFE).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 19 Dec 2023, 16:37.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
Additional SEC filing notes
Footnote F1
Each unit represents one phantom share of common stock.
Footnote F2
This transaction constitutes an intra-plan transfer to acquire Pfizer stock units in the Pfizer stock unit fund under the Pfizer Inc. Deferred Compensation Plan.
Footnote F3
The units, held under the Deferred Compensation Plan, are paid in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.